Skip to content

Clinical trials

Phase 1/2 Neoplasm Metastasis trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 1/2 Country / region: Singapore Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20141
20191
20202
20211
20223
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Active, not recruiting3
Completed3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Nuvalent Inc.2
Array BioPharma1
Ascendis Pharma Oncology Division A/S1
Eikon Therapeutics1
PMV Pharmaceuticals, Inc1
Puma Biotechnology, Inc.1
Synthorx, Inc, a Sanofi company1
Turning Point Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis12
Breast Neoplasms3
Colorectal Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Endometrial Neoplasms2
Lung Neoplasms2
Gallbladder Neoplasms1
Glioblastoma1
Glioma1
Granuloma, Plasma Cell1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.